user

Phase III and phase IV trials: Noninvasive assessment of efficacy endpoints in vessel walls

被引：2
|
作者：
Levenson, J [1 ]
Simon, A [1 ]
机构：
[1] Hop Broussais, Ctr Med Prevent Cardiovasc, INSERM, F-75674 Paris, France
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 81卷 / 8A期
关键词：
D O I：
10.1016/S0002-9149(98)00268-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：67F / 68F
页数：2
相关论文
共 50 条
  • [1] Endpoints for Phase III Trials
    van den Bent, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S40 - S40
  • [2] Interphase clinical trials: Phase III/Phase IV
    O'Quigley, J
    Xu, RH
    Blin, P
    Charpak, Y
    [J]. BIOMETRICAL JOURNAL, 1999, 41 (07) : 773 - 782
  • [3] Primary endpoints of phase III trials for older patients with cancer
    Mizutani, T.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1187 - S1187
  • [4] Endpoints for Phase II Trials
    Chang, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S40 - S40
  • [5] Balancing Phase II and III efficacy trials
    Sandage, BW
    [J]. DRUG INFORMATION JOURNAL, 1998, 32 (04): : 977 - 980
  • [6] Balancing Phase II and III Efficacy Trials
    Bobby W. Sandage
    [J]. Drug information journal : DIJ / Drug Information Association, 1998, 32 (4): : 977 - 980
  • [7] Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials
    Sherry, Alexander D.
    Lin, Timothy A.
    McCaw, Zachary R.
    Beck, Esther J.
    Kouzy, Ramez
    Abi Jaoude, Joseph
    Passy, Adina H.
    Miller, Avital M.
    Kupferman, Gabrielle S.
    Fuller, Clifton David
    Thomas, Charles R.
    Koay, Eugene J.
    Tang, Chad
    Msaouel, Pavlos
    Ludmir, Ethan B.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2024,
  • [8] Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials
    Shinya Watanabe
    Takahiro Nonaka
    Makoto Maeda
    Narushi Sugii
    Koichi Hashimoto
    Shingo Takano
    Tomoyoshi Koyanagi
    Masanobu Yamada
    Yoshihiro Arakawa
    Eiichi Ishikawa
    [J]. Therapeutic Innovation & Regulatory Science, 2023, 57 : 603 - 610
  • [9] Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials
    Watanabe, Shinya
    Nonaka, Takahiro
    Maeda, Makoto
    Sugii, Narushi
    Hashimoto, Koichi
    Takano, Shingo
    Koyanagi, Tomoyoshi
    Yamada, Masanobu
    Arakawa, Yoshihiro
    Ishikawa, Eiichi
    [J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (03) : 603 - 610
  • [10] Optimal planning of phase II/III programs for clinical trials with multiple endpoints
    Kieser, Meinhard
    Kirchner, Marietta
    Doelger, Eva
    Goette, Heiko
    [J]. PHARMACEUTICAL STATISTICS, 2018, 17 (05) : 437 - 457
12345